|
Current and novel therapeutic approaches in myelodysplastic syndromes
|
Jul 2014
|
J Community Support Oncol
|
myelodysplastic syndromes (MDS)
|
|
Current concepts in the pathophysiology and treatment of aplastic anemia
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
aplastic anemia
|
|
Current outcome of HLA identical sibling vs. unrelated donor transplants in severe aplastic anemia: an EBMT analysis
|
Jan 2015
|
Haematologica
|
aplastic anemia
|
|
Current state of prognostication and risk stratification in myelodysplastic syndromes
|
Mar 2015
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes
|
Aug 2016
|
Clin Lymphoma Myeloma Leuk.
|
myelodysplastic syndromes (MDS)
|
|
Current therapy of myelodysplastic syndromes.
|
Jul 2013
|
Blood Rev
|
myelodysplastic syndromes (MDS)
|
|
Cutting edge: flow cytometry in myelodysplastic syndromes
|
Jul 2013
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|
|
Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies
|
Mar 2015
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Cyclophosphamide in severe aplastic anemia?
|
Oct 2014
|
Blood
|
aplastic anemia
|
|
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro
|
Jun 2020
|
Experimental Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
